trial

Side Effects of Newer Antipsychotics in Older Adults

NCTId NCT00245206
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 406 (actual)
Sponsored by Veterans Medical Research Foundation
Primary completion 2010-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
406 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2005-08
Primary completion
2010-10
Eligibility
ALL · 40 Years

Interventions & indications

Drugs
AripiprazoleOlanzapineRisperidone

Sponsors

Veterans Medical Research FoundationLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Dilip V. Jeste, MDPrincipal Investigator

Sites

1 total
San Diego, United States

Facts & assertions

4 sourced
Enrollment
406
Phase
PHASE4
Primary Completion Date
2010-10
Status
COMPLETED
relationships
The graph out of here
drug
Aripiprazole
drug
Olanzapine
drug
Risperidone
drug
lead_sponsor
Veterans Medical Research Foundation
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Dementia
indication
Dementia
indication
Diabetes Mellitus
indication
investigator
Dilip V. Jeste, MD
person